validating ctdna-based approaches in clinical trials
Published 2 years ago • 100 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
0:40
expanding the use of ctdna in clinical trials
-
25:12
nccm 2024 | analytical & clinical validation circulating tumor dna-based assay
-
1:24
a cg ctdna-based prognostic model for predicting os in mcrpc treated with potent ar inhibition
-
4:26
fundamentals of ctdna
-
0:56
ctdna sensitivity in early-stage disease
-
2:16
applications of ctdna in clinical practice
-
1:23
role of ctdna in mrd
-
0:42
ctdna in clinical practice for melanoma
-
1:20:03
webinar on liquid biopsy for cancer diagnostics & therapeutic monitoring
-
11:15
chorioallantoic membrane (cam) assay: tools and techniques | jptv
-
3:22
galleri test versus circulating tumor dna test: a cancer doctor explains
-
6:58
personalizing ctdna analysis to predict crc relapse
-
3:25
understand ctdna testing
-
2:02
applications of ctdna in lung cancer: informing treatment approaches, mrd and screening
-
8:04
“circulate” clinical trial evaluating ctdna dynamics and clinical outcomes in colon cancer
-
4:23
illumina oncology - clinical utility of ctdna testing
-
4:25
technical considerations for ctdna testing in nsclc
-
1:33
climb360: ctdna-based molecular screening
-
6:58
liquid biopsy: introduction to ctdna
-
9:35
methods for ctdna detection and analysis
-
1:12
ctdna clearance linked to improved outcomes in mibc neoadjuvant therapy: results from volga study
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma